Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Modern Diagnostic & Research Centre PB Ratio?
Modern Diagnostic & Research CentreBOM:544673 15 PB Ratio is 1.32 as of Aug. 27, 2026, which is 33% below its 10-year median of 1.96. GuruFocus rates BOM:544673 with a GF Score™ of 15/100. The stock has 7 warning signs investors should review. Among 192 Medical Diagnostics & Research companies, Modern Diagnostic & Research Centre ranks better than 70.31% on this metric.
BOM:544673's PB Ratio is ranked better than 70.31% of 192
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.095
vs BOM:544673: 1.32
During the past 12 months, Modern Diagnostic & Research Centre's average Book Value Per Share Growth Rate was 182.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 114.10% per year.
During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Modern Diagnostic & Research Centre was 114.10% per year. The lowest was 114.10% per year. And the median was 114.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Modern Diagnostic & Research Centre PB Ratio Related Terms
Modern Diagnostic & Research Centre PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Modern Diagnostic & Research Centre PB Ratio Chart
Modern Diagnostic & Research Centre Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
PB Ratio
0.00
0.00
0.00
1.38
Modern Diagnostic & Research Centre Semi-Annual Data
Mar23
Mar24
Mar25
Mar26
PB Ratio
0.00
0.00
0.00
1.38
BOM:544673 vs TMO, DHR, IDXX: PB Ratio Comparison
For the Diagnostics & Research subindustry, Modern Diagnostic & Research Centre's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Modern Diagnostic & Research Centre PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Modern Diagnostic & Research Centre's PB Ratio distribution charts can be found below:
* The bar in red indicates where Modern Diagnostic & Research Centre's PB Ratio falls into.
Modern Diagnostic & Research Centre PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Modern Diagnostic & Research Centre (BOM:544673) has a PB Ratio of 1.32 as of Aug. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Modern Diagnostic & Research Centre and its competitors. This is 33% below median its historical median of 1.96. Over the past decade, Modern Diagnostic & Research Centre's PB Ratio has ranged from 1.26 to 6.84. According to the industry distribution chart, Modern Diagnostic & Research Centre ranks #57 out of 192 companies in the Medical Diagnostics & Research industry, placing it in the top 29.7%.
Is Modern Diagnostic & Research Centre's PB Ratio too high?
Modern Diagnostic & Research Centre's current PB Ratio of 1.32 is 33% below median its 10-year median of 1.96. Over the past 10 years, this metric has ranged from a low of 1.26 to a high of 6.84. The Medical Diagnostics & Research industry median PB Ratio is 2.10. Modern Diagnostic & Research Centre's value of 1.32 is 37% below this industry median. Based on the distribution chart, Modern Diagnostic & Research Centre ranks #57 out of 192 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Modern Diagnostic & Research Centre has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Modern Diagnostic & Research Centre's PB Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Modern Diagnostic & Research Centre ranks #57 out of 192 companies for PB Ratio. This puts Modern Diagnostic & Research Centre in the upper half of its industry. The industry median PB Ratio is 2.10. Modern Diagnostic & Research Centre's value of 1.32 is 37% below this benchmark. Historically, Modern Diagnostic & Research Centre's own PB Ratio has ranged from 1.26 to 6.84 over the past decade. While the company's 10-year median is 1.96 vs. the industry median of 2.10, Modern Diagnostic & Research Centre has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 2.10, based on 192 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Modern Diagnostic & Research Centre's current PB Ratio of 1.32 is 37% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Modern Diagnostic & Research Centre and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Modern Diagnostic & Research Centre's current PB Ratio is 1.32, which is 33% below median its own 10-year median of 1.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Diagnostic & Research Centre stock overvalued right now?
Modern Diagnostic & Research Centre (BOM:544673) has a current PB Ratio of 1.32. The current PB Ratio is 1.32, which is 33% below median its 10-year median of 1.96 and 37% below the Medical Diagnostics & Research industry median of 2.10. Modern Diagnostic & Research Centre's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Modern Diagnostic & Research Centre (BOM:544673), the current PB Ratio is 1.32 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Modern Diagnostic & Research Centre Ltd is a services provider in diagnostic and related healthcare tests services in India. It offers a one-stop solution for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory. Through Its integrated, nationwide network, it offers a complete range of diagnostic facilities in radiology and pathology. The company provides healthcare tests and services for use in core testing, patients' diagnosis and prevention, monitoring of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
15GF Score
Get the complete analysis for BOM:544673
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544673 has been successfully added to your 
